Skip to main content

Hinge Health, Inc. (HNGE) Stock Analysis

Recovery setup

SellVALUE-TRAP 2/5Moderate Confidence

Healthcare · Health Information Services

Sell if holding. At $54.96, A.R:R 1.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Health Care Service Corporation (17.5%); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3).

Hinge Health is a digital musculoskeletal (MSK) care platform serving self-insured employers and health plans, using AI-powered motion tracking and licensed physical therapists to treat joint and muscle conditions remotely. Revenue is generated on a per-member engagement basis,... Read more

$54.96+15.8% A.UpsideScore 6.1/10#4 of 13 Health Information Services
QualityF-score5 / 9FCF yield10.56%
Stop $51.11Target $63.66(analyst − 10%)A.R:R 1.1:1
Analyst target$70.73+28.7%15 analysts
$63.66our TP
$54.96price
$70.73mean
$95

Sell if holding. At $54.96, A.R:R 1.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Health Care Service Corporation (17.5%); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3). Chart setup: Death cross but MACD improving, RSI 84. Score 6.1/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 77d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

Recent Developments — Hinge Health, Inc.

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Attractive valuation
Risks
Concentration risk — Customer: Health Care Service Corporation (17.5%)
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3)
Leverage penalty (D/E 2.2): -1.5

Key Metrics

P/E (TTM)
P/E (Fwd)17.5
Mkt Cap$4.2B
EV/EBITDA-7.9
Profit Mgn-78.9%
ROE-136.0%
Rev Growth47.2%
Beta
DividendNone
Rating analysts22

Quality Signals

Piotroski F5/9MoatNarrow

Options Flow

P/C0.42bullish
IV64%elevated

Concentration Risks(10-K Item 1A)

  • HIGHCustomerHealth Care Service Corporation18%
    10-K Item 1A: 'client contracts through (i) Health Care Service Corporation ("HCSC") accounted for 17.5% and 17.1% of our revenue, respectively'
  • MEDIUMCustomerElevance Health, Inc.14%
    10-K Item 1A: '(ii) Elevance Health, Inc., formerly known as Anthem, Inc. ("Elevance"), accounted for 13.7% and 14.0% of our revenue, respectively'
  • MEDIUMCustomerAetna Life Insurance Company11%
    10-K Item 1A: '(iii) Aetna Life Insurance Company ("Aetna") accounted for 10.5% and 11.6% of our revenue, respectively'

Material Events(8-K, last 90d)

  • 2026-03-17Item 5.02LOW
    Tyler Sloat appointed as Class I director effective March 16, 2026, serving as Chair of Compensation Committee and member of Audit Committee. Mr. Sloat is COO of Freshworks Inc. No officer departure involved.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.0
Value Rank
1.5
Growth Rank
9.2
Industry growth leader

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
1.1
Bollinger
2.6
52w Position
7.7
GatesA.R:R 1.1 < 1.5@spotMomentum 6.6>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 77d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
84 · Overbought
20D MA 50D MA 200D MADEATH CROSSSupport $42.31Resistance $56.50

Price Targets

$51
$64
A.Upside+15.8%
A.R:R1.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Reward/Risk 1.1:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-04 (77d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HNGE stock a buy right now?

Sell if holding. At $54.96, A.R:R 1.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Health Care Service Corporation (17.5%); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3). Chart setup: Death cross but MACD improving, RSI 84. Prior stop was $51.11. Score 6.1/10, moderate confidence.

What is the HNGE stock price target?

Take-profit target: $63.66 (+15.8% upside). Prior stop was $51.11. Stop-loss: $51.11.

What are the risks of investing in HNGE?

Concentration risk — Customer: Health Care Service Corporation (17.5%); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3); Leverage penalty (D/E 2.2): -1.5.

Is HNGE overvalued or undervalued?

Hinge Health, Inc. trades at a P/E of N/A (forward 17.5). TrendMatrix value score: 7.3/10. Verdict: Sell.

What do analysts say about HNGE?

22 analysts cover HNGE with a consensus score of 4.1/5. Average price target: $71.

What does Hinge Health, Inc. do?Hinge Health is a digital musculoskeletal (MSK) care platform serving self-insured employers and health plans, using...

Hinge Health is a digital musculoskeletal (MSK) care platform serving self-insured employers and health plans, using AI-powered motion tracking and licensed physical therapists to treat joint and muscle conditions remotely. Revenue is generated on a per-member engagement basis, primarily through contracts with large national health plans acting as channel partners. Client contracts through partners accounted for 82% of revenue in 2025, with HCSC at 17.5%, Elevance at 13.7%, and Aetna at 10.5%.

Related stocks: WAY (Waystar Holding Corp.) · VEEV (Veeva Systems Inc.) · HQY (HealthEquity, Inc.) · PRVA (Privia Health Group, Inc.) · MMED (MiniMed Group, Inc.)